PharmaResearch Rejuran® at ASCD ETCD 2023 in Australia

ASCD are proud to present the Emerging Trends In Cosmetic Dermatology Symposium for 2023.

Rejuran®, the flagship brand of Pharma Research (CEOs Thinkyou Kim and Ki-seok Kang), Is poised to make a significant entry into Australia, the largest aesthetics market in Oceania.

The Australasian Society of Cosmetic Dermatologists (ASCD) have kept to their demand this year for education, with numerous events covering all aspects of cosmetic dermatology. This exciting initiative for a single day event showcased areas that often are neglected in or need more attention than they receive in mainstream conferences.

Approximately 150 delegates descended on Melbourne for a single day ASCD event on November 13, termed as the Emerging Trends in Cosmetic Dermatology. It was an in-depth evidence-based look into 5 areas of Dermatology that deserve more attention than they normally would occupy in our main conference.

PharmaResearch unveiled Rejuran at ASCD ETCD 2023 hosted in Melbourne. Australia November 13, and presented the excellence and latest insights about its patented DNA Optimizing Technology (DOT™), a manufacturing method for PDRN and PN, with more than 150 local healthcare professionals.

Rejuran® is a medical device manufactured with polynucleotide (PN), a salmon-derived restorative substance, that applies PharmaResearch's patented DNA Optimizing Technology (DOT™) for the improvement of physical appearance.